UBC anticorps (N-Term)
Aperçu rapide pour UBC anticorps (N-Term) (ABIN4889895)
Antigène
Voir toutes UBC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Reacts with the N-terminus part of human UBC / Ubiquitin C
-
Purification
- Purified (protein G)
-
Immunogène
- KLH conjugated synthetic peptide selected from the N-terminal region of human Ubiquitin.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IHC-P (10 μg/mL), WB (1:100 - 1:500) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, Sodium azide 0.09 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Date de péremption
- 6 months
-
-
- UBC (Ubiquitin C (UBC))
-
Autre désignation
- UBC / Ubiquitin C
-
Sujet
- UBC protein is a polyubiquitin precursor. Conjugation of ubiquitin monomers or polymers can lead to various effects within a cell, depending on the residues to which ubiquitin is conjugated. Ubiquitination has been associated with protein degradation, DNA repair, cell cycle regulation, kinase modification, endocytosis, and regulation of other cell signaling pathways.
-
Pathways
- Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Mitotic G1-G1/S Phases, DNA Replication, Toll-Like Receptors Cascades, Synthesis of DNA, EGFR Downregulation, Ubiquitin Proteasome Pathway
Antigène
-